Literature DB >> 9098912

Relationship between asbestos bodies in sputum and the number of specimens.

F Sulotto1, E Capellaro, A Chiesa, S Villari, S Bontempi, G Scansetti.   

Abstract

OBJECTIVES: This study investigated the relationship between asbestos body identification and the number of sputum specimens obtained from each subject.
METHODS: The presence of asbestos bodies in sputum was studied in 142 asbestos workers with former low-exposure levels; the number of specimens collected during 1-3 weeks varied from 2 to more than 4. Furthermore the persistence of asbestos bodies in the sputum of 15 asbestos workers was studied during a long-time follow-up.
RESULTS: Asbestos bodies were present in at least 1 specimen in 44.4% of the 142 subjects. The cumulative percentage of asbestos body presence increased linearly, from 20% to 68%, as the number of specimens increased.
CONCLUSIONS: Five specimens did not seem to be sufficient to obtain satisfactory sensitivity in a group with low exposure to asbestos. Neither the type of exposure (to chrysotile only or to chrysotile plus amphibole) nor the presence of an asbestos-related disease clearly influenced the probability of finding asbestos bodies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9098912     DOI: 10.5271/sjweh.178

Source DB:  PubMed          Journal:  Scand J Work Environ Health        ISSN: 0355-3140            Impact factor:   5.024


  2 in total

1.  Comparative analysis of induced sputum and bronchoalveolar lavage fluid (BALF) profile in asbestos exposed workers.

Authors:  Evangelos C Alexopoulos; Demosthenes Bouros; Maria Dimadi; Aneta Serbescu; Giorgos Bakoyannis; Fivos P Kokkinis
Journal:  J Occup Med Toxicol       Date:  2011-08-14       Impact factor: 2.646

2.  Fluoro-edenitic fibres in the sputum of subjects from Biancavilla (Sicily): a pilot study.

Authors:  Maria Grazia Putzu; Caterina Bruno; Amerigo Zona; Marilena Massiccio; Roberto Pasetto; Pier Giorgio Piolatto; Pietro Comba
Journal:  Environ Health       Date:  2006-06-16       Impact factor: 5.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.